par Marketing | Mar 17, 2023 | fibroids treatment, fibroids, Uterine Fibroid Embolisation, Women in White
DYK that 90% of women who undergo UFE experience significant or complete resolution of their symptoms? 🙌 If you suffer from fibroids, UFE could be the non-invasive and permanent solution you’ve been looking for. Send us a message to request an information...
par Marketing | Mar 15, 2023 | Fallopian Tube Recanalization (FTR), Fallopian Tubes, Women in White
The short answer is, YES 💐 Fallopian Tube Recanalization (FTR) is fully covered by most medical aids. However, if you are unsure please reach out to your provider directly as they will be the most reliable source to confirm 🌸 If you have been diagnosed with blocked...
par Marketing | Mar 9, 2023 | Fallopian Tube Recanalization (FTR), fibroids treatment, fibroids, Geniculate Artery Embolization (GAE), Uterine Fibroid Embolisation, Women in White
Offering you a ‘no-scalpel’ option to treat uterine fibroids, blocked fallopian tubes and osteoarthritis of the knee 🙌 These procedures have proven to drastically improve quality of life, without the painful recovery time of an invasive surgery. If you have been...
par Marketing | Mar 8, 2023 | Cintocare, Fallopian Tube Recanalization (FTR), fibroids treatment, fibroids, Geniculate Artery Embolization (GAE), Uterine Fibroid Embolisation
It’s all about green today 🍀 Cintocare is the first Green Star SA certified hospital in South Africa, and the first Green Star rated healthcare facility in Africa 💚 The Microsurgery team could not be prouder to add Cintocare Pretoria as a routine operating location....
par Marketing | Mar 7, 2023 | Fallopian Tube Recanalization (FTR), fibroids treatment, Geniculate Artery Embolization (GAE), Uterine Fibroid Embolisation, Women in White
Hello Gauteng, the Microsurgery is expanding ✨Now operating from Life Fourways Hospital, Netcare Parklane, and CintoCare Pretoria 🌷 If you’ve been diagnosed with fibroids and wish to undergo non-invasive and permanent treatment, visit our contact page...
